Advances in the Management of Moderate-to-Severe Atopic Dermatitis

Activity Overview

For over 50 years, Pam suffered with uncontrolled moderate-to-severe atopic dermatitis (AD). She experienced the evolution of treatment strategies over the course of several decades, trying everything from topicals to off-label targeted systemic agents. She was willing to try anything to make the unbearable itch go away. In this roundtable discussion, we brought Pam and her dermatologist to discuss AD with a multidisciplinary physician panel. Together they weigh in on experimental and newly approved therapies, management strategies, impact on quality-of-life, and shared decision-making techniques, all supplemented by Pam’s unfiltered, down-to-earth reality check of what life with AD and all these drugs really feels like.

0.50 CE Credit(s)
Expires: October 16, 2020

Target Audience

The target audience for this activity is US-based dermatologists, allergists, and immunologists, as well as NPs and PAs that diagnose and manage atopic dermatitis (AD). Primary care clinicians will also be included as a secondary audience.

Learning Objectives

Upon successful completion of this education activity, participants should be better able to:

  • Apply current principles of pathophysiology of atopic dermatitis (AD) and the concept of atopic march to therapeutic approaches to disease management
  • Develop treatment plans for patients with AD that reflect evidence-based guidelines, use of new and emerging therapeutic options, assessment of treatment response, and strategies to optimize short-term control and long-term management of the disease
  • Assess for and manage quality-of-life issues and psychosocial comorbidities in patients with AD
  • Utilize shared decision making and develop treatment plans that will result in high levels of adherence and better patient outcomes

Activity Faculty

Peter A. Lio, MD

Peter A. Lio, MD (Chair)

Assistant Professor, Clinical Dermatology and Pediatrics
Northwestern University
Feinberg School of Medicine
Ann & Robert H. Lurie Children’s Hospital
Chicago, IL

Mark Boguniewicz, MD

Mark Boguniewicz, MD

Professor, Division of Allergy-Immunology
Department of Pediatrics
National Jewish Health and University of Colorado School of Medicine
Denver, CO

Eric L. Simpson, MD, MCR

Eric L. Simpson, MD, MCR

Professor, Dermatology
Director, Clinical Research
Department of Dermatology
Oregon Health & Science University
Portland, OR